ANGO

Over the past six months, AngioDynamics' stock price has fluctuated, decreasing by 12.8% since January 1st, 2026, but increasing by 14.29% in the past month. Key events include the Q3 2026 earnings report with net sales of $78.4 million, an 8.9% year-over-year increase, and a loss of ($0.07) per share, beating consensus estimates. Other events include Q2 and Q1 2026 earnings reports, a patent suit filed to protect its thrombectomy technology, analyst coverage with "buy" recommendations, and the upcoming retirement of CEO Jim Clemmer.